Competition Law Alert
ORDERS By COMPETITION
COMMISSION OF INDIA
A. Anti-Competitive
Agreements
Synopsis
of the legal provisions
Section 3 of the Competition Act, 2002 (“Act”) prohibits an enterprise or association of enterprises or
persons to enter into agreements in respect of production, supply,
distribution, storage, acquisition or control of goods or provision of
services, which causes or is likely to cause appreciable adverse effect on
competition in India.
Following kinds of agreements between
enterprises, persons or association of persons or enterprises, or practices or
decisions taken by association of persons or enterprises, including cartels,
engaged in similar or identical trade of goods or provision of services
is presumed to have appreciable adverse effect on competition:
a)
Agreements or decisions that directly or indirectly
determine purchase or sale price.
b) Agreements that limit or control production, supply,
market, technical development, investment or provision of services.
c) Agreements to share market or source of production
or provision of services by way of allocation of geographical area of market or
type of goods or services, or number of customers in the market or any other
similar way.
d)
Agreements that, directly or indirectly, result in bid-rigging
or collusive bidding.
However, agreements entered into by
way of joint ventures are excluded from above restriction if such agreements
increase the efficiency in production, supply, distribution, acquisition, or
control of goods or provision of services.
Under the Act, ‘cartel includes an association of producers, sellers, distributors,
traders, or service providers who, by agreement amongst themselves, limit
control or attempt to control the production, distribution, sale or price of,
or trade in goods, or provision of services’.
Further, under section 19(3) of the
Act, following factors are to be considered by Competition
Commission of India (“CCI”) in determining whether an agreement
has appreciable adverse effect on competition:
a)
Creation of barriers to new entrants in the market.
b)
Driving existing competitors out of the market.
c)
Foreclosure of competition by hindering entry into
the market.
d)
Accrual of benefits to consumers.
e)
Improvement in production or distribution of goods
or provision of services.
f)
Promotion of technical, scientific and economic
development by means of production or distribution of goods or provision of
services.
B.
Abuse of Dominant Position
Synopsis
of legal provisions
Section 4 of the Act
prohibits any enterprise or group to abuse its dominant position. ‘Dominant
position’ has been defined to mean ‘a
position of strength enjoyed by an enterprise, in the relevant market, in
India, which enables it to –
(i)
operate independently of competitive forces prevailing in the relevant
market; or
(ii)
affect its competitors or consumers or the relevant market in its favor’.
In light of the above provisions, we produce the summary of CCI’s orders
passed in the month of January, 2014:
1. Awadh Bihari Singh v. Petroleum and
Natural Gas Regulatory Board, decided on January 2, 2014
The
case filed by Awadh Bihar Singh (“Informant”)
against Petroleum and Natural Gas Regulatory Board (“PNGRB”) alleging that the amendments in PNGRB Act, 2006 (“PNGRB Act”) will encourage
anti-competitiveness and abuse of dominance in the market.
PNGRB
regulates downstream segments of oil and gas distribution, including City Gas
Distribution (“CGD”). PNGRB issue
bids for authorizing natural gas distribution networks. Informant alleged that
some companies of CGD segment have dominance in the said segment.
Informant
further submitted that by way of PNGRB (Authorizing Entities to Lay, Build,
Operate or Expand City or Local Natural Gas Distribution Networks) Amendment
Regulations, 2013, PNGRB has proposed fresh norms for aforementioned bidding
process.
Informant
alleged that the said amendment regulations are in conflict with the provisions
of the PNGRB Act and would lead to abuse of dominant position held by the
established CGD companies, restrict competition, induce formation of cartel,
escalate cost of bid bonds to unacceptable levels and unnecessary increase in
CGD project cost.
CCI
observed that under the PNGRB Act, PNGRB is authorized to formulate regulations
to regulate the sector. However, these regulations are required to be put
before both the houses of Parliament for its approval. Therefore, the
regulations framed by PNGRB are merely subordinate legislation. Informant
alleged that such subordinate legislation was contrary to the substantive
provisions of the PNGRB Act. CCI held that the Informant should approach the
appropriate forum if his grievance in respect of the scope of powers of PNGRB.
CCI does not have jurisdiction to take cognizance of the case involving
legislative powers of PNGRB.
Based
on the above observations, CCI ordered for closure of the case.
2. Tunuguntla Chandra Shekar and
Tunuguntla Sudha Rani v. M/s S.G. Estates Limited and Others decided on January
2, 2014
Mr.
Tunuguntla Chandra Shekar and Ms. Tunuguntla Sudha Rani (“Informants”) filed a case against, M/s S.G. Estates Limited and M/s
SKI View Hotel Private Limited (“Defendant Developers”) alleging
violation of section 4 of the Act.
Informants
submitted that in the year 2006 they had booked a space in the commercial real
estate project of Defendant Developers at Ghaziabad. As per the Informants, the
scheduled date of possession was March 31, 2008.
Informants
contended that the said project was not completed within the stipulated time
and construction deficiencies were also not removed. Informant further alleged
sale deed was heavily one sided and in favor of Defendant Developers.
Informants
alleged that the Defendant Developers have made unreasonable demands for
maintenance charges, which was not based on the actual expenditure. They
further submitted that Defendant Developers have not provided completion
certificate of municipality.
Informant
stated that at the time of booking of space in the year 2006, the Defendant
Developers were the sole player in the market of commercial real estate segment.
CCI
noted that the relevant market in the present case shall be the market of development and sale of commercial space in
Ghaziabad.
On
the basis of information available in the public domain, CCI observed that
there are many other players in the relevant market. Therefore, on the basis of
presence of other significant player in the market, CCI held that Defendant
Developers are not a dominant player in the market. Therefore no prima facie
case of violation of Section 4 of the Act could be established. Hence, CCI
ordered for closure of the case.
- Shyam Lal Gupta v.
Cravatex Limited, decided on January2, 2014
The
case was filed by Mr. Shyam Lal Gupta (“Informant”)
against Cravetex Limited (“Cravatex”)
alleging abuse of dominance.
Informant
submitted that in the year 2009, he had purchased a Treadmill from Cravatex for
Rs. 27,000. Later in the year 2012, his treadmill went out of order and he
approached Cravatex for repair. He was informed by Cravatex that electric motor
and MCB board of the tread mill were damaged and needed to be replaced. The
replacement cost of the aforesaid parts was stated to be Rs. 28,838, which is
more than the purchase price of the treadmill.
Informant
alleged that Cravatex is the only pan India Fitness Company with 50 stores in
major cities.
In
its reply, Cravatex informed CCI that Informant purchased tread mill for Rs.
27,000 at the time of stock clearance sale, whereas the actual purchase price
of that treadmill was Rs. 40,900. Cravatex also informed that Informant has not
extended warranty of the treadmill and has also not taken any annual
maintenance services. Therefore, Cravatex concluded that Informant has used the
treadmill, without any periodic maintenance.
Cravatex
submitted that it does not manufacture fitness machines, as it only imports
such machines from its original manufacturers. Therefore the price quoted for
replacement was based on the cost to its manufacturer.
On
the basis of the primary functioning of the motorized treadmills, CCI observed
that different versions of motorized treadmills are substitutable. Therefore,
CCI decided that relevant market in the present case shall be the market for
sale of motorized treadmills in India.
On
the basis of information available in public domain, CCI observed that there
are other players in the market, which manufactures and imports motorized
treadmills such as Cosco, Reebok and JERAI. As per CCI, all aforementioned
players claim to be the biggest. CCI noted that Informant has not provided any
information to prove dominance of Cravatex, except the number of stores across
India. However, CCI noted that there are other players, which have stores more
than that of Cravatex.
Therefore
based on the above mentioned observations, CCI held that Cravatex is not a
dominant player in the market. Hence, CCI ordered for closure of the case.
- Surinder Saini v. Delhi Metro Rail Corporation Ltd. & Ors.
The
case was filed by Shri Surinder Saini (‘Informant”)
against Delhi Metro Corporation Limited and 5 other institutions (“Defendant Institutions”) alleging abuse
of dominance. Informant runs a firm called M/s Medical Product Services.
Informant
stated that in past his firm and two other firms were found in violation of
Section 3(3)(d) of the Act by CCI and the same was also upheld by Competition
Appellate Tribunal (COMPAT).
Informant
submitted that Defendant Institutions issue tenders for supply of Medical
Operation Theatre (MOT) and Medical Gas Pipeline System (MGPS). However, the
terms of the tenders restrict such firms, which have been found guilty of bid
rigging or cartelization.
Informant
informed that there are only 5-6 major players supplying MOT and MGPS, whereas
the other players play a very small role. Informant alleged that Defendant
Institutions have taken collusive action to restrict its entry in the market.
Informant further alleged that Defendant Institutions are government
procurement agencies and therefore they are abusing their dominant position by
inserting such an anti-competitive condition in their tenders.
CCI
stated that the practice of debarring those firms, which were found guilty of
contravention of provisions of the Act is completely in the interest of public
at large and can never be considered as unfair and arbitrary. CCI further
stated that Defendant Institutions are consumers and they can put such
conditions to safeguard their interest as a consumer.
CCI
further observed that Defendant Institutions have imposed conditions in their
tenders based on the order of CCI and COMPAT, which is in public domain, therefore
actions of Defendant Institutions cannot be called to collusive.
Based
on the above observations, CCI held that the said case cannot be examined under
Sections 3 and 4 of the Act. Therefore, CCI ordered for closure of the case.
- Sreeram Mushty, Chartered
Accountant v. Shriram Chits Limited
The
case was filed by CA Sreeram Mushty (“Informant”)
against Sriram Chits Limited (“SCL”)
alleging abuse of dominance.
Informant
submitted that in the year 1996, he participated with his associates in the
chit group of SCL namely BLX-01 with ticket numbers 26, 30 and 35.
Informant
alleged that SCL has wrongfully invoked clause 17 of the standard chit fund
agreement and has exercised a right of lien over the prize money of aforesaid
tickets. Informant further submitted that there was no outstanding amount to be
paid on such tickets by him.
Informant
alleged that SCL has deposited the prize money of the ticket number 35 as fixed
deposit in one of the group company of SCL, when informant failed to pay an
instalment. Informant further alleged that SCL has declared Informant as
defaulter subscriber and has denied dividends on the chits.
Aggrieved
with the above conduct of SCL, Informant has approached CCI.
CCI
noted that in the present case the relevant product market is the ‘market of
chit fund services’. CCI opined that
the ‘market of chit fund services’
is different from conventional banking system, as it entails credit without any
collateral security and rate of interest on deposits are relatively higher than
any other saving instruments. Therefore, chit fund is a unique product and
pertains to a different market.
CCI
further noted that chit funds companies need to be registered with the state
government and operate under the regulations of their respective states. SCL is
registered in Andhra Pradesh, therefore the relevant geographical market shall
be Andhra Pradesh.
CCI
stated that Informant has not provided any data to establish dominance of the
SCL. CCI noted that the 65.55% of the market share of the total chit fund
business in India (excluding Kerala) is covered by Margadarsi Chit Funds and
SCL. Whereas, Margdarsi accounts of 41.67% and SCL holds 23.88%. However, CCI
noted that there is no information on state wise share of chit fund business.
Therefore it cannot be ascertained whether SCL is dominant player in the state
of Andhra Pradesh. CCI further stated that Informant has not provided any data
in the aforesaid respect and there is also no information available even in the
public domain.
Based
on the above observations, CCI held that SCL does not appear to be dominant
player in the relevant market. Therefore it ordered for closure of the case.
- In re: Pan India
Infra Projects Private Limited and Board of Cricket Control in India
decided on January 16, 2014
The
case was filed by Pan India Infra Projects Private Limited (“Pan India”) against Board of Cricket
Control in India (“BCCI”) alleging
abuse of dominance in the organization of private cricket leagues.
CCI
noted that in February, 2013 it has already decided in its order that BCCI is a
dominant player and abused its dominant position. The issue of hostile
behaviour towards private cricket league was also dealt in detail in the said
order. CCI further noted that in its earlier order, CCI found that BCCI’s approval
for initiating any cricketing league was crucial. CCI in its earlier order also
held that BCCI has entered into an agreement, whereby it was restricted to give
permission for any other private league. Therefore, it was decided that by not
allowing ICL, BCCI has abused its dominance.
CCI
noted that the said order was challenged by BCCI before COMPAT and appeal is
pending. However, COMPAT has put a stay on the impugned order of CCI. CCI
further noted that Pan India has also filed Special Leave Petition before
Supreme Court against BCCI citing same grievances. The said SLP is also
pending.
Therefore,
based on the above observations CCI stated that there is no need to start a
fresh investigation against BCCI as all the grievance of the Pan India have already
been addressed in its earlier order.
CCI
held that if COMPAT upheld order of CCI and even after that BCCI continue to
abuse its dominance, than in such case Pan India will have a right to approach
CCI.
C.
Combination Registrations
1.
Combination Registration No. C-2013/12/143 decided
on January 7, 2014
The notice for
the combination was filed by Mahindra Engineering Services Limited (“MES”) and Tech Mahindra Limited (“Tech Mahindra”). As per the proposed
combination, the entire business comprised in all undertakings of MES will get
amalgamated into Tech Mahindra.
MES is an
unlisted company incorporated in India. It provides engineering services
comprising of designing and developing parts etc. for automotive and
off-highways sector.
Tech Mahindra is
a listed company incorporated in India. It provides engineering services
largely in the aerospace, automotive, industrial hi-tech and consumer
electronics sectors.
As per the
notice, Mahindra & Mahindra Limited directly and indirectly holds 80.69% of
the share capital of MES. Mahindra & Mahindra Limited together with its
promoters also holds 36.46% of share capital of Tech Mahindra.
Based on the
above facts, CCI held that the proposed combination will not have adverse
effect on the competition in market. Therefore, CCI approved the combination.
2.
Combination Registration No. C-2013/12/146 decided
on January 30, 2014
The notice for
combination was filed by Inox Air Products Limited (“Inox”). The proposed combination was in respect of Business
Transfer Agreement between Inox and Essar Steel Limited (“Essar”). As per the proposed combination, Esaar’s gas plant
situated at Gujarat will be transferred to Inox on slump sale basis.
Inox is
incorporated in India and is engaged in business of manufacturing and supplying
industrial gases, including oxygen, nitrogen, helium, argon.
Essar is also
incorporated in India and is an integrated steel manufacturer. The gas plant at
Gujarat produces oxygen, nitrogen, and argon gases. However, the said gases are
primarily used for captive purposes at its steel plants.
On the basis of
information provided by Inox and Essar, CCI noted that Inox and Essar will
enter into a Job Work Agreement. As per the said Job Work Agreement, Inox will
provide industrial gases to Essar for its steel plants. CCI also noted that
post combination the total production capacity of Inox will not increase
significantly.
Therefore, based
on the above observations, CCI held that proposed combination will not have
appreciable adverse effect on the competition. Hence, CCI approve the
combination.
3.
Combination Registration No. C-2013/10/136 decided
on January 30, 2014
The notice for
the combination was filed by Synnex
Corporation (“Synnex”). The proposed
combination is in respect of a Master Asset Purchase Agreement between Synnex
and International Business Machines Corporation (“IBM”). As per the proposed combination, Synnex will acquire
customer relationship management business process outsourcing (“CRM BPO”) of IBM.
IBM has two wholly owned subsidiaries in India,
namely, IBM India Private Limited (“IBM
India”) and IBM Daksh Business Process Service Private Limited (“IBM Daksh”). As per the proposed
combination, BPO business of IBM Daksh will get transferred to Synnex.
Synnex is NYSE listed company and is engaged in the
business of providing BPO services to resellers, retailers and original
equipment manufacturers of various industries. Apart from BPO business, it is
also engaged inter alia in the business providing IT distribution,
supply chain management. In India, Synnex operates through its wholly owned
subsidiary Concentrix Technologies (India) Private Limited (“Concentrix”).
IBM is also a NYSE listed company engaged in the
business of manufacturing and marketing computer hardware and software. It also
provides infrastructure hosting and consulting services in the areas from
mainframe computers to nanotechnology. As stated above, IBM has two
subsidiaries in India i.e. IBM Daksh and IBM India. Both the subsidiaries are
engaged in providing BPO services in customer care and back office works.
As per the combination, the Indian operations of IBM
will also get transferred together with CRM BPO business of IBM.
CCI noted that the major portion of the revenue of IBM
Daksh are generated from exports. Similarly, Concentrix revenue from domestic
market is also insignificant. CCI further stated that IT BPO industry of India
has several large players. Therefore, based on the above observations and
analysis, CCI held that the proposed combination will not have appreciable
adverse effect on the competition in India. Hence, CCI approved the
combination.
4.
Combination Registration No. C-2014/01/149 decided
on January 30, 2014
The notice for the
combination was field by HDFC Trustee Company Limited (“HDFC Trustee”)
and HDFC Asset Management Company Limited (“HDFC AMC”) (HDFC Trustee and
HDFC AMC collectively be referred as “Acquirers”).
The proposed combination was filed pursuant to a Scheme Transfer Agreement
between Acquirers and Morgan Stanley Mutual Fund (“MS Trustees”) and
Morgan Stanley Investment Management Private Limited (“MS AMC”) (MS
Trustees and MS AMC be collectively referred to as “MS Entities”).
As per the
proposed combination, Acquirers will acquire eight Morgan Stanley Mutual Fund
(“MS Mutual Fund”) schemes from MS
Entities.
As per the notice,
HDFC Mutual Fund is a trust established under Indian Trusts Act, 1882, which is
co-sponsored by HDFC Corporation Limited and Standard Life Investments Limited.
HDFC AMC is the asset management company and HDFC Trustee is trustee of HDFC
Mutual Fund. HDFC Mutual Fund is registered under the Securities and Exchange
Board of India (Mutual Funds) Regulations, 1996 (“SEBI Mutual Fund
Regulations”).
MS Mutual Fund is
a trust established under Indian Trusts Act, 1882 sponsored by Morgan Stanley.
MS AMC is the asset management company of MS Mutual Fund.
CCI observed that
mutual fund business in India is regulated by SEBI Mutual Fund Regulations. As per the official website of SEBI, there are
52 registered mutual funds operating in India. Therefore, there is an ample
choice to customers to shift from one mutual fund to other. Moreover, as per
the report of Association of Mutual Funds of India, the average asset
under management of MS Mutual Fund for the last quarter was insignificant.
Therefore based on
the above observations, CCI held that the proposed combination will note have
appreciable adverse effect on competition. Hence, CCI approved the combination.
5.
Combination Registration No. C-2013/12/145 decided
on January 28, 2014
The notice for the
combination was filed by KKR Floorline Investments Pte Ltd (“KKR Floorline”) and Gland Celsus Bio
Chemicals Private Limited (“Gland Celus”).
The proposed combination was pursuant to the following agreements:
1.
Shares Subscription Agreement
between Gland Pharma Limited ( “Gland
Pharma”), the promoters of Gland Pharma and KKR Floorline.
2.
Shareholders Agreement amongst
Gland Pharma, the promoters of Gland Pharma and KKR Floorline.
3.
Share Purchase Agreement
amongst KKR Floorline, Gland Pharma and EILSF Co-Invest I LLC (private equity
investor of Gland Pharma).
4.
Share Subscription Agreement
amongst Gland Celsus, the promoters of Gland Celsus and KKR Floorline.
As per the
proposed combination, in terms of the above mentioned agreements, KKR Floorline
will acquire 37.98% of equity shares of Gland Pharma and 24.9% of equity shares
of Gland Celus. Further, Gland Celus will subscribe to additional securities of
Gland Pharma, which will increase its shareholding in Gland Pharma to 30.24%.
KKR Floorline is
an investment holding company incorporated in Singapore. KKR Floorline is
controlled by KKR & Co. LP (“KKR”)
incorporated in Delaware, USA. KKR is a global asset funds and investment
company, which holds investments in various companies in India.
Gland Pharma is a
company incorporated in India, engaged in producing generic versions of
medicines and specialized injectables. Further, Gland Pharma also produces
active pharmaceutical ingredients (“API”)
for in-house consumption.
Gland Celus is an
investment holding company and is promoter of Gland Pharma. It currently holds
17.70 % of equity share capital of Gland Pharma, 12.98 per cent of equity share
capital of Gland Chemicals Private Limited (“Gland Chemicals”) and 40 %
equity share capital of Nicomac Clean Rooms Far East Private Limited (“Nicomac”).
As per the notice
filed, Gland Celus does not carry on any business whereas, Gland Chemicals
produces API and Nicomac manufactures and supplies modular clean room systems,
lab services, equipment etc.
CCI noted that KKR
holds investment in three health care companies in India. Out of the said three
companies, one is engaged in business of providing solutions to medical devise
market, the second company is engaged in business of dosage delivery product
and the third company is engaged in the business of contract research and
clinical development services to the biotechnology and pharmaceutical
industries globally.
On the basis of
the information provided by the parties, CCI observed that Gland Pharma does
not have any vertical relationship with the aforesaid three companies in which
KKR holds investments.
CCI further
observed that there is a horizontal overlapping of products of said three
companies and Gland Pharma and other companies in which Gland Celus has
investment. However, the supply of APIs from Gland Chemicals to Gland Pharma or
the clean room products from Nicomac to Gland Pharma is not significant enough
to result in any competition concern in India.
Therefore based on
the above observations, CCI held that proposed combination will not have
appreciable adverse effect on the competition in India. Hence, CCI approved the
combination.
D.
News
1.
Competition Commission cautions against
unfair ways in pharma business
CCI vide a public
notice has listed out various possible anti-competitive practices in the pharma
sector. The said notice is addressed to general public, chemists, druggists,
stockists of medicines, whole-sellers and pharmaceutical
manufacturers.
The CCI in its several
orders had already found several practices with regard to cases concerning all
India, state-level, district-level associations of chemists, druggists,
stockists, whole-sellers and manufacturers to be anti-competitive.
Few of such
anti-competitive practices include (i) issuance of instructions to
chemists/druggists/shops/ stockists/whole-sellers/manufacturers restricting
discounts on sale of drugs in retail or wholesale; (ii) issuance of boycott
calls by the associations to their members against any enterprise for not
following their instructions; and (iii) fixation of trade margins at different
levels of sale of drugs or medicines.
According to the
notice, CCI has already issued cease & desist order against the
associations directing them not to indulge in anti-competitive practices. Therefore,
non-compliance of the order of will entail severe penalties and can even lead to prosecution.
2.
Coal India appeals against CCI's Rs 1,773
crore penalty order
Coal India has
moved to the Competition Appellate Tribunal against a CCI order slapping Rs
1,773 crore penalty on it for unfair trade practices.
CCI in its order
observed that Coal India is operating independently of market
forces and enjoys an undisputed dominance in the country for production
and supply of non-coking coal.
According to the said
order, Coal India abused its dominance and did not try to evolve/draft/finalise
terms and conditions of Fuel Supply Agreements through a mutual bilateral
process with procurers. CCI has also directed Coal India to cease and desist
from certain anti-competitive
practices.
3.
Government exempts shipping vessel sharing
pacts from CCI purview
As per the gazette
notification issued by the Ministry of Corporate Affairs, the Central Government
has exempted Vessel Sharing Agreements among shipping companies from the ambit
of CCI for a period of one year.
Vessel Sharing
Agreement allows entities to share space in each other’s
vessels is a common practice in the shipping industry. The shipping
industry has been seeking exemption for these pacts from the purview of section
3 of the Act (anti-competitive agreements).
Therefore now
throughout the exemption period, Vessel Sharing
Agreement would only be monitored by the Director General of
Shipping.
4.
Competition Commission of India may probe
price-fixing in RCF tender
As per the news
reports, CCI is looking into an alleged formation of cartel between two railway
brake manufacturers, namely Knorr Bremse and Faiveley Transport, when they
quoted identical prices for the tenders floated for rail brakes by the Railway
Coach Factory at Kapurthala in Punjab.
According to a complaint filed by Railway Coach Factory, Kapurthala, the Indian subsidiaries of German braking system maker Knorr Bremse and French railway equipment maker Faiveley Transport have formed a cartel to supply ‘Axle Mounted Disk-Break System’ for coaches at Railway Coach Factory. In its complaint to CCI, the complainant has claimed that the two bids were totally identical on three occasions in 2011, when the department had floated emergency tenders.
5.
Competition Commission of India orders
another probe against Coal India
CCI has ordered an
investigation against Coal India and
its subsidiary Western Coalfields on a complaint alleging that the company has
abused its dominant position. The investigation is ordered on basis of a
complaint from Wardha Power that alleged that the state-run entity forced it to
enter into a one-sided Fuel Supply Agreement (FSA) under which the
latter did not have bargaining power or power to negotiate. Wardha Power has
further alleged that Coal India has increased the price of the coal that was
supplied to it from Rs. 1613/- per metric tonne to Rs. 2177/- per metric tonne,
without justifying the hike in prices.
CCI in its latest
order held that a prima facie case was made out against Western
Coalfields and Coal India for investigation for contravention of Section 4 of
the Competition Act. Accordingly, investigation was ordered.
CCI had already
penalised Coal India and its subsidiaries heavily for abuse of
dominance by imposing a penalty of Rs 1773 crore in the month of December, 2013.
Coal India has challenged the said December order before COMPAT.
**********************************************************
DISCLAIMER
This
competition law alert has been prepared by Sarthak Advocates and Solicitors. It
is meant to be merely an informative summary and should not be treated as a
substitute for considered legal advice. We welcome your comments and
suggestions. For any comments, suggestions or further clarifications, please
contact us at:
Sarthak Advocates & Solicitors
A-35, Sector - 2, Noida- 201 301,
Uttar Pradesh
Boardline: +91- 120-4309050
Fax: +91- 120-4249060
Email:
knowledge@sarthaklaw.com